Induction of AR Transactivation by DHT and E2
DHT 和 E2 诱导 AR 反式激活
基本信息
- 批准号:6790025
- 负责人:
- 金额:$ 27.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2005-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Provided by the applicant)
Androgens, acting through the androgen receptor (AR), mediate a wide spectrum
of developmental and physiological processes, including the development and
maintenance of the prostate. However, it has recently been shown that AR can be
transcriptionally activated in vitro by 17(3-estradiol (E2) in the presence of
the AR coregulator ARA70. In rodent models, neonatal exposure to exogenous
estrogen results in a dose dependent alteration of adult prostate size and
histology. However, targeted disruption of the estrogen receptors (ER) a and P
in mice do not conclusively show a role for either ER in prostate development,
potentially indicating that exogenous estrogens may be acting at least in part
through AR to influence prostate growth. Estrogens and androgens are
structurally similar with the major difference occurring at the C-3 position of
the steroidal A-ring where dihydroxytestosterone (DHT) carries a keto group and
E2 carries a phenolic hydroxyl. To investigate the amino acid residues of AR
that mediate the ability of E2 to induce AR transcription, and the mechanism
through which coregulators differentiate between DHT- and E2-bound AR, we
propose in Specific Aim I to isolate mutations of AR that transcriptionally
respond to DHT but not E2. In Specific Aim 2, we will isolate AR mutants the
preferentially respond to E2. In Specific Aim 3, we will isolate specific
coregulators that differentially interact with DHT- or E2-bound AR. In Specific
Aim 4, we will determine the mechanism of DHT or E2 induced transcription of AR
in the presence of AR coregulators. Finally, in Specific Aim 5 we will
determine the effect of E2 induction of AR transcription in prostate cells. The
success of this proposal will not only allow us to understand how E2 regulates
AR transcription, but will also provide information on transcription by AR in
response to different ligands, which may ultimately lead to novel therapeutic
approaches to prostate cancer.
描述(由申请人提供)
雄激素通过雄激素受体(AR)发挥作用,
发育和生理过程,包括发育和
前列腺的保养然而,最近有证据表明,AR可以
在存在17 β-雌二醇(E2)的情况下,
AR协同调节因子ARA 70。在啮齿动物模型中,新生儿暴露于外源性
雌激素导致成人前列腺大小的剂量依赖性改变,
组织学然而,靶向破坏雌激素受体(ER)a和P
在小鼠中没有最终显示ER在前列腺发育中的作用,
这可能表明外源性雌激素可能至少部分地
通过AR来影响前列腺的生长。雌激素和雄激素是
结构相似,主要差异发生在C-3位,
类固醇A环,其中二羟基睾酮(DHT)携带酮基,
E2带有酚羟基。研究AR的氨基酸残基
介导E2诱导AR转录的能力,
通过这些辅助调节子区分DHT和E2结合的AR,我们
在具体目标I中提出分离AR的突变,
对DHT有反应,但对E2无反应。在特定目标2中,我们将分离AR突变体,
优先选择E2。在特定目标3中,我们将分离特定
与DHT或E2结合的AR差异性相互作用的辅助调节因子。在特定
目的4、探讨DHT或E2诱导AR基因转录的机制
在AR辅助调节剂的存在下。在第五章中,我们将
确定前列腺细胞中E2诱导AR转录的作用。的
这项提议的成功不仅使我们能够了解E2如何调节
AR转录,但也将提供关于AR转录的信息,
反应不同的配体,这可能最终导致新的治疗
前列腺癌的治疗方法
项目成果
期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Androgen suppresses PML protein expression in prostate cancer CWR22R cells.
雄激素抑制前列腺癌 CWR22R 细胞中 PML 蛋白的表达。
- DOI:10.1016/j.bbrc.2003.12.060
- 发表时间:2004
- 期刊:
- 影响因子:3.1
- 作者:Yang,Lin;Yeh,Shauh-Der;Xie,Shaozhen;Altuwaijri,Saleh;Ni,Jing;Hu,Yueh-Chiang;Chen,Yen-Ta;Bao,Bo-Ying;Su,Ching-Hua;Chang,Chawnshang
- 通讯作者:Chang,Chawnshang
Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor.
- DOI:10.1084/jem.20031233
- 发表时间:2003-12-15
- 期刊:
- 影响因子:0
- 作者:Yeh S;Hu YC;Wang PH;Xie C;Xu Q;Tsai MY;Dong Z;Wang RS;Lee TH;Chang C
- 通讯作者:Chang C
Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
雄激素受体阴性前列腺癌细胞中抗雄激素羟基氟他胺激活丝裂原激活蛋白激酶途径。
- DOI:
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:Lee,Yi-Fen;Lin,Wen-Jye;Huang,Jiaoti;Messing,EdwardM;Chan,FrankyL;Wilding,George;Chang,Chawnshang
- 通讯作者:Chang,Chawnshang
Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells.
- DOI:10.1016/s0006-291x(03)00792-7
- 发表时间:2003-06
- 期刊:
- 影响因子:3.1
- 作者:Lin Yang;Liang Wang;Hui-Kuan Lin;Pu-Yeh Kan;Shaozhen Xie;M. Tsai;Peng-Hui Wang;Yen-Ta Chen;Chawnshang Chang
- 通讯作者:Lin Yang;Liang Wang;Hui-Kuan Lin;Pu-Yeh Kan;Shaozhen Xie;M. Tsai;Peng-Hui Wang;Yen-Ta Chen;Chawnshang Chang
Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator.
- DOI:
- 发表时间:2003-08
- 期刊:
- 影响因子:11.2
- 作者:K. Nishimura;H. Ting;Y. Harada;T. Tokizane;N. Nonomura;Hong-Yo Kang;Hong-Chiang Chang;S. Yeh;H. Miyamoto;M. Shin;K. Aozasa;A. Okuyama;Chawnshang Chang
- 通讯作者:K. Nishimura;H. Ting;Y. Harada;T. Tokizane;N. Nonomura;Hong-Yo Kang;Hong-Chiang Chang;S. Yeh;H. Miyamoto;M. Shin;K. Aozasa;A. Okuyama;Chawnshang Chang
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHAWNSHANG CHANG其他文献
CHAWNSHANG CHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHAWNSHANG CHANG', 18)}}的其他基金
Non-AR mediated DHT-promoted Bladder Cancer initiation and progression
非 AR 介导的 DHT 促进膀胱癌的发生和进展
- 批准号:
8527735 - 财政年份:2011
- 资助金额:
$ 27.91万 - 项目类别:
Stromal AR Roles in Prostate Hyperplasia and Cancer
基质 AR 在前列腺增生和癌症中的作用
- 批准号:
8459341 - 财政年份:2011
- 资助金额:
$ 27.91万 - 项目类别:
Stromal AR Roles in Prostate Hyperplasia and Cancer
基质 AR 在前列腺增生和癌症中的作用
- 批准号:
8053554 - 财政年份:2011
- 资助金额:
$ 27.91万 - 项目类别:
Stromal AR Roles in Prostate Hyperplasia and Cancer
基质 AR 在前列腺增生和癌症中的作用
- 批准号:
8830282 - 财政年份:2011
- 资助金额:
$ 27.91万 - 项目类别:
Non-AR mediated DHT-promoted Bladder Cancer initiation and progression
非 AR 介导的 DHT 促进膀胱癌的发生和进展
- 批准号:
8693963 - 财政年份:2011
- 资助金额:
$ 27.91万 - 项目类别:
Stromal AR Roles in Prostate Hyperplasia and Cancer
基质 AR 在前列腺增生和癌症中的作用
- 批准号:
8628080 - 财政年份:2011
- 资助金额:
$ 27.91万 - 项目类别:
Non-AR mediated DHT-promoted Bladder Cancer initiation and progression
非 AR 介导的 DHT 促进膀胱癌的发生和进展
- 批准号:
8115717 - 财政年份:2011
- 资助金额:
$ 27.91万 - 项目类别:
Androgen Receptor in B Cell Development and Functions
B 细胞发育和功能中的雄激素受体
- 批准号:
7996771 - 财政年份:2010
- 资助金额:
$ 27.91万 - 项目类别:
New Mice Models for Studies of Androgen Receptor in Prostate Cancer
用于研究前列腺癌雄激素受体的新小鼠模型
- 批准号:
7996057 - 财政年份:2008
- 资助金额:
$ 27.91万 - 项目类别:
New Mice Models for Studies of Androgen Receptor in Prostate Cancer
用于研究前列腺癌雄激素受体的新小鼠模型
- 批准号:
8204965 - 财政年份:2008
- 资助金额:
$ 27.91万 - 项目类别:
相似国自然基金
增生性玻璃体视网膜病变早期钙黏蛋白(Cadherins)异常表达启动视网膜色素上皮细胞游离的分子机制
- 批准号:81770939
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
Beta-catenin/Cadherins, EphBs 在平衡颅神经嵴细胞的粘附和迁徙机制的研究
- 批准号:81400494
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
Cadherins与nectins在青少年期慢性社会应激损害小鼠前额叶形态可塑性与功能中的作用
- 批准号:81401129
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Contribution of Endothelial Planar Cell Polarity pathways in Blood Flow Direction Sensing
内皮平面细胞极性通路在血流方向传感中的贡献
- 批准号:
10750690 - 财政年份:2024
- 资助金额:
$ 27.91万 - 项目类别:
Basis and Function of Lateral Assembly of Cadherin Molecules in Adhesive Junctions of Humans and Model Organisms
人类和模型生物粘附连接中钙粘蛋白分子横向组装的基础和功能
- 批准号:
10715056 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Characterizing and Targeting ERBB2 Mutations in Invasive Lobular Carcinoma
侵袭性小叶癌中 ERBB2 突变的特征和靶向
- 批准号:
10749213 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Investigating the epidermal microenvironment in melanoblast migration and invasion: a novel approach to understanding invasive melanoma
研究黑色素细胞迁移和侵袭的表皮微环境:一种了解侵袭性黑色素瘤的新方法
- 批准号:
10537221 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Phosphatase-dependent regulation of desmosome intercellular junctions
桥粒细胞间连接的磷酸酶依赖性调节
- 批准号:
10677182 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Diversity Supplement: Novel Role of Nephron Epithelialization in Nuclear Signaling
多样性补充:肾单位上皮化在核信号传导中的新作用
- 批准号:
10853534 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Developing a nonsteroidal and nonhormonal agent that reverses menopause-related loss of genital epithelial integrity and function
开发一种非类固醇和非激素药物,可逆转更年期相关的生殖器上皮完整性和功能丧失
- 批准号:
10901049 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Investigating mechanisms of tissue polarity during development and disease
研究发育和疾病过程中组织极性的机制
- 批准号:
10751262 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:














{{item.name}}会员




